Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SABS
Stock Latest News
Company Announcements
SAB Biotherapeutics Updates SAB-142 Roadmap and Funding Outlook
4d ago
8K
SABS
Premium
Company Announcements
SAB Biotherapeutics Appoints New Independent Board Chair, Directors
9d ago
8K
SABS
Premium
The Fly
SAB Biotherapeutics initiated with a Buy at UBS
9d ago
SABS
Premium
The Fly
Aligos Therapeutics initiated with a Buy at UBS
9d ago
IVA
KOD
Premium
The Fly
SAB Biotherapeutics appoints David Zaccardelli as board chair
9d ago
SABS
Premium
The Fly
SAB Biotherapeutics files $300M mixed securities shelf
17d ago
SABS
Premium
Company Announcements
SAB Biotherapeutics Launches New $75 Million ATM Program
18d ago
8K
SABS
Premium
Ratings
SAB Biotherapeutics: Favorable SAB-142 Safety Profile and De-Risked Phase 2b Design Underpin Buy Rating
28d ago
SABS
Premium
The Fly
SAB Biotherapeutics initiated with a Buy at Guggenheim
29d ago
SABS
Premium
The Fly
SAB Biotherapeutics announces first patient dosed in SAFEGUARD trial
29d ago
SABS
Premium
The Fly
SAB Biotherapeutics Phase 1 trial of SAB-142 met primary endpoint
1M ago
SABS
Premium
The Fly
Eleven new option listings and two option delistings on December 8th
1M ago
UL
DOOO
Premium
The Fly
SAB Biotherapeutics to present data on progress in development of SAB-142
1M ago
SABS
Premium
Company Announcements
SAB Biotherapeutics Reports Positive Q3 2025 Earnings
2M ago
SABS
Premium
Pre-Earnings
Sab Biotherapeutics, Inc. (SABS) Q3 Earnings Cheat Sheet
2M ago
SABS
Premium
Ratings
Promising Clinical Developments and Strategic Decisions Justify Buy Rating for SAB Biotherapeutics
2M ago
SABS
Premium
Ratings
Promising Phase 1 Data for SAB-142 Supports Buy Rating for SAB Biotherapeutics
2M ago
SABS
Premium
Company Announcements
Sab Biotherapeutics’ New Study Targets Type 1 Diabetes Progression
3M ago
SABS
Premium
Company Announcements
SAB Biotherapeutics Board Members Resign in Agreement
4M ago
8K
SABS
Premium
Company Announcements
SAB Biotherapeutics Approves Equity Plan Amendments
4M ago
8K
SABS
Premium
Ratings
Promising Developments and Strategic Partnerships Drive Buy Rating for SAB Biotherapeutics’ SAB-142
4M ago
SABS
Premium
The Fly
SAB Biotherapeutics highlights data in multiple presentations at EASD
4M ago
SABS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
